S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
On the money: Yellen's next milestone is name on US currency
Biden releasing nearly $36B to aid pensions of union workers
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Are Investors Hearing The End Of Spotify's Downtrend?
Is It Time To Throw In The Towel On Gamestop?
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
On the money: Yellen's next milestone is name on US currency
Biden releasing nearly $36B to aid pensions of union workers
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Are Investors Hearing The End Of Spotify's Downtrend?
Is It Time To Throw In The Towel On Gamestop?
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
On the money: Yellen's next milestone is name on US currency
Biden releasing nearly $36B to aid pensions of union workers
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Are Investors Hearing The End Of Spotify's Downtrend?
Is It Time To Throw In The Towel On Gamestop?
S&P 500   3,963.51
DOW   33,781.48
QQQ   283.85
101 Christmas Gift Ideas Under $40
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
This Is Why Daktronics Fell 40% In One Day 
Why You Should Avoid Carvana Even if it Avoids Bankruptcy
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
On the money: Yellen's next milestone is name on US currency
Biden releasing nearly $36B to aid pensions of union workers
The One Ticker Retirement Plan Over the Shoulder Demo Now Available (Ad)
Are Investors Hearing The End Of Spotify's Downtrend?
Is It Time To Throw In The Towel On Gamestop?
NASDAQ:BLFS

BioLife Solutions - BLFS Stock Forecast, Price & News

$19.80
+0.42 (+2.17%)
(As of 12/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$18.71
$20.23
50-Day Range
$17.30
$25.07
52-Week Range
$10.40
$41.75
Volume
246,857 shs
Average Volume
394,561 shs
Market Capitalization
$846.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$31.20

BioLife Solutions MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
57.6% Upside
$31.20 Price Target
Short Interest
Bearish
7.66% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.94mentions of BioLife Solutions in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$2.18 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.63) to ($0.37) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.12 out of 5 stars

Medical Sector

482nd out of 1,022 stocks

Electromedical Equipment Industry

11th out of 23 stocks

BLFS stock logo

About BioLife Solutions (NASDAQ:BLFS) Stock

BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.

Receive BLFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter.

BLFS Stock News Headlines

BioLife Solutions (NASDAQ:BLFS) Trading Down 2.3%
BioLife Solutions Expands Intellectual Property Estate
Earnings Outlook For BioLife Solutions
BioLife Solutions Inc
BioLife Solutions Inc. News
BioLife Solutions, Inc. (BLFS)
See More Headlines
Receive BLFS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter.

BLFS Company Calendar

Last Earnings
11/11/2021
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/27/2023

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:BLFS
Employees
432
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$31.20
High Stock Price Forecast
$34.00
Low Stock Price Forecast
$29.00
Forecasted Upside/Downside
+57.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-7,640,000.00
Pretax Margin
-72.07%

Debt

Sales & Book Value

Annual Sales
$119.16 million
Book Value
$11.80 per share

Miscellaneous

Free Float
41,355,000
Market Cap
$846.77 million
Optionable
Not Optionable
Beta
1.72

Key Executives

  • Michael P. RiceMichael P. Rice
    Chairman & Chief Executive Officer
  • Roderick de Greef
    President & Chief Operating Officer
  • Troy WichtermanTroy Wichterman
    Chief Financial Officer
  • Aby J. MathewAby J. Mathew
    Chief Scientific Officer & Executive VP
  • Karen FosterKaren Foster
    Chief Quality Officer













BLFS Stock - Frequently Asked Questions

Should I buy or sell BioLife Solutions stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BioLife Solutions in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" BLFS shares.
View BLFS analyst ratings
or view top-rated stocks.

What is BioLife Solutions' stock price forecast for 2023?

1 Wall Street analysts have issued 1 year price objectives for BioLife Solutions' shares. Their BLFS share price forecasts range from $29.00 to $34.00. On average, they anticipate the company's share price to reach $31.20 in the next twelve months. This suggests a possible upside of 57.6% from the stock's current price.
View analysts price targets for BLFS
or view top-rated stocks among Wall Street analysts.

How have BLFS shares performed in 2022?

BioLife Solutions' stock was trading at $37.27 on January 1st, 2022. Since then, BLFS shares have decreased by 46.9% and is now trading at $19.80.
View the best growth stocks for 2022 here
.

Are investors shorting BioLife Solutions?

BioLife Solutions saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 3,030,000 shares, an increase of 16.1% from the October 31st total of 2,610,000 shares. Based on an average daily trading volume, of 355,800 shares, the days-to-cover ratio is currently 8.5 days. Currently, 7.7% of the company's shares are short sold.
View BioLife Solutions' Short Interest
.

When is BioLife Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our BLFS earnings forecast
.

How were BioLife Solutions' earnings last quarter?

BioLife Solutions, Inc. (NASDAQ:BLFS) released its earnings results on Thursday, November, 11th. The medical equipment provider reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.21. The medical equipment provider had revenue of $33.80 million for the quarter, compared to analysts' expectations of $31.65 million. BioLife Solutions had a negative trailing twelve-month return on equity of 7.50% and a negative net margin of 67.70%. During the same period in the previous year, the firm posted ($0.02) EPS.

What guidance has BioLife Solutions issued on next quarter's earnings?

BioLife Solutions updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $160.00 million-$164.00 million, compared to the consensus revenue estimate of $163.40 million.

What is Mike Rice's approval rating as BioLife Solutions' CEO?

14 employees have rated BioLife Solutions Chief Executive Officer Mike Rice on Glassdoor.com. Mike Rice has an approval rating of 100% among the company's employees. This puts Mike Rice in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. 89.0% of employees surveyed would recommend working at BioLife Solutions to a friend.

What other stocks do shareholders of BioLife Solutions own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BioLife Solutions investors own include Micron Technology (MU), AbbVie (ABBV), Cara Therapeutics (CARA), Gilead Sciences (GILD), Pfizer (PFE), Rigel Pharmaceuticals (RIGL), Sorrento Therapeutics (SRNE), Twilio (TWLO) and Verastem (VSTM).

What is BioLife Solutions' stock symbol?

BioLife Solutions trades on the NASDAQ under the ticker symbol "BLFS."

Who are BioLife Solutions' major shareholders?

BioLife Solutions' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (12.66%), Vanguard Group Inc. (5.65%), Fred Alger Management LLC (5.06%), Geneva Capital Management LLC (3.61%), State Street Corp (2.88%) and Palisade Capital Management LLC NJ (2.16%). Insiders that own company stock include Aby J Mathew, Aby J Mathew, Amy Duross, Andrew G Hinson, Andrew G Hinson, Casdin Partners Master Fund, L, Greef Roderick De, James Mathers, Joseph C Schick, Karen A Foster, Karen A Foster, Marcus Schulz, Michael Rice, Of The University Of C Regents, Raymond W Cohen, Sarah Aebersold, Thomas Girschweiler, Todd Berard, Troy Wichterman and Walter Villiger.
View institutional ownership trends
.

How do I buy shares of BioLife Solutions?

Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is BioLife Solutions' stock price today?

One share of BLFS stock can currently be purchased for approximately $19.80.

How much money does BioLife Solutions make?

BioLife Solutions (NASDAQ:BLFS) has a market capitalization of $846.85 million and generates $119.16 million in revenue each year. The medical equipment provider earns $-7,640,000.00 in net income (profit) each year or ($2.48) on an earnings per share basis.

How many employees does BioLife Solutions have?

The company employs 432 workers across the globe.

How can I contact BioLife Solutions?

BioLife Solutions' mailing address is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. The official website for the company is www.biolifesolutions.com. The medical equipment provider can be reached via phone at (425) 402-1400, via email at rdegreef@biolifesolutions.com, or via fax at 425-402-1433.

This page (NASDAQ:BLFS) was last updated on 12/9/2022 by MarketBeat.com Staff